Structural features of membrane-bound glucocerebrosidase and α-synuclein probed by neutron reflectometry and fluorescence spectroscopy
- PMID: 25429104
- PMCID: PMC4295019
- DOI: 10.1074/jbc.M114.610584
Structural features of membrane-bound glucocerebrosidase and α-synuclein probed by neutron reflectometry and fluorescence spectroscopy
Abstract
Mutations in glucocerebrosidase (GCase), the enzyme deficient in Gaucher disease, are a common genetic risk factor for the development of Parkinson disease and related disorders, implicating the role of this lysosomal hydrolase in the disease etiology. A specific physical interaction exists between the Parkinson disease-related protein α-synuclein (α-syn) and GCase both in solution and on the lipid membrane, resulting in efficient enzyme inhibition. Here, neutron reflectometry was employed as a first direct structural characterization of GCase and α-syn·GCase complex on a sparsely-tethered lipid bilayer, revealing the orientation of the membrane-bound GCase. GCase binds to and partially inserts into the bilayer with its active site most likely lying just above the membrane-water interface. The interaction was further characterized by intrinsic Trp fluorescence, circular dichroism, and surface plasmon resonance spectroscopy. Both Trp fluorescence and neutron reflectometry results suggest a rearrangement of loops surrounding the catalytic site, where they extend into the hydrocarbon chain region of the outer leaflet. Taking advantage of contrasting neutron scattering length densities, the use of deuterated α-syn versus protiated GCase showed a large change in the membrane-bound structure of α-syn in the complex. We propose a model of α-syn·GCase on the membrane, providing structural insights into inhibition of GCase by α-syn. The interaction displaces GCase away from the membrane, possibly impeding substrate access and perturbing the active site. GCase greatly alters membrane-bound α-syn, moving helical residues away from the bilayer, which could impact the degradation of α-syn in the lysosome where these two proteins interact.
Keywords: Gaucher Disease; Membrane Bilayer; Parkinson Disease; Protein-Lipid Interaction; Surface Plasmon Resonance (SPR); Tryptophan.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.
Figures
Similar articles
-
Alpha-synuclein interacts with Glucocerebrosidase providing a molecular link between Parkinson and Gaucher diseases.J Biol Chem. 2011 Aug 12;286(32):28080-8. doi: 10.1074/jbc.M111.237859. Epub 2011 Jun 8. J Biol Chem. 2011. PMID: 21653695 Free PMC article.
-
Saposin C protects glucocerebrosidase against α-synuclein inhibition.Biochemistry. 2013 Oct 15;52(41):7161-3. doi: 10.1021/bi401191v. Epub 2013 Oct 1. Biochemistry. 2013. PMID: 24070323 Free PMC article.
-
Glucocerebrosidase deficiency promotes release of α-synuclein fibrils from cultured neurons.Hum Mol Genet. 2020 Jun 27;29(10):1716-1728. doi: 10.1093/hmg/ddaa085. Hum Mol Genet. 2020. PMID: 32391886 Free PMC article.
-
Involvement of Gaucher Disease Mutations in Parkinson Disease.Curr Protein Pept Sci. 2017;18(7):758-764. doi: 10.2174/1389203717666160311115956. Curr Protein Pept Sci. 2017. PMID: 26965692 Review.
-
Glucocerebrosidase dysfunction in neurodegenerative disease.Essays Biochem. 2021 Dec 22;65(7):873-883. doi: 10.1042/EBC20210018. Essays Biochem. 2021. PMID: 34528667 Review.
Cited by
-
GBA1 Variants and Parkinson's Disease: Paving the Way for Targeted Therapy.J Mov Disord. 2023 Sep;16(3):261-278. doi: 10.14802/jmd.23023. Epub 2023 Jun 12. J Mov Disord. 2023. PMID: 37302978 Free PMC article.
-
Binding Behavior between Transforming-Growth-Factor-Beta1 and Its Receptor Reconstituted in Biomimetic Membranes.Membranes (Basel). 2023 Apr 19;13(4):446. doi: 10.3390/membranes13040446. Membranes (Basel). 2023. PMID: 37103873 Free PMC article.
-
The Consequences of GBA Deficiency in the Autophagy-Lysosome System in Parkinson's Disease Associated with GBA.Cells. 2023 Jan 3;12(1):191. doi: 10.3390/cells12010191. Cells. 2023. PMID: 36611984 Free PMC article. Review.
-
Neuronopathic Gaucher disease: Beyond lysosomal dysfunction.Front Mol Neurosci. 2022 Aug 3;15:934820. doi: 10.3389/fnmol.2022.934820. eCollection 2022. Front Mol Neurosci. 2022. PMID: 35992201 Free PMC article. Review.
-
Parkinson's Disease Associated with GBA Gene Mutations: Molecular Aspects and Potential Treatment Approaches.Acta Naturae. 2021 Apr-Jun;13(2):70-78. doi: 10.32607/actanaturae.11031. Acta Naturae. 2021. PMID: 34377557 Free PMC article.
References
-
- Hardy J., Cai H., Cookson M. R., Gwinn-Hardy K., Singleton A. (2006) Genetics of Parkinson's disease and parkinsonism. Ann. Neurol. 60, 389–398 - PubMed
-
- Lesage S., Anheim M., Letournel F., Bousset L., Honoré A., Rozas N., Pieri L., Madiona K., Dürr A., Melki R., Verny C., Brice A., and French Parkinson's Disease Genetics Study Group (2013) G51D α-synuclein mutation causes a novel parkinsonian-pyramidal syndrome. Ann. Neurol. 73, 459–471 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
